Neuronal and glial markers are differently associated with computed tomography findings and outcome in patients with severe traumatic brain injury: a case control study.
about
Blood Biomarkers for Evaluation of Perinatal EncephalopathySystems biology approaches for discovering biomarkers for traumatic brain injuryYear in review 2010: Critical Care--Neurocritical careBlood biomarkers for brain injury: What are we measuring?Combining biochemical and imaging markers to improve diagnosis and characterization of mild traumatic brain injury in the acute setting: results from a pilot studySyndromics: a bioinformatics approach for neurotrauma researchClinical review: neuromonitoring - an update.Serial Sampling of Serum Protein Biomarkers for Monitoring Human Traumatic Brain Injury Dynamics: A Systematic Review.CSF and plasma amyloid-β temporal profiles and relationships with neurological status and mortality after severe traumatic brain injuryUbiquitin carboxy-terminal hydrolase L1 (UCH-L1) is increased in cerebrospinal fluid and plasma of patients after epileptic seizureGFAP out-performs S100β in detecting traumatic intracranial lesions on computed tomography in trauma patients with mild traumatic brain injury and those with extracranial lesions.Outcome prediction after mild and complicated mild traumatic brain injury: external validation of existing models and identification of new predictors using the TRACK-TBI pilot study.Human traumatic brain injury induces autoantibody response against glial fibrillary acidic protein and its breakdown products.Biomarkers as outcome predictors in subarachnoid hemorrhage--a systematic reviewSignificance of ubiquitin carboxy-terminal hydrolase L1 elevations in athletes after sub-concussive head hitsMeasurement of the glial fibrillary acidic protein and its breakdown products GFAP-BDP biomarker for the detection of traumatic brain injury compared to computed tomography and magnetic resonance imaging.Biomarkers in neurocritical care.Serum UCH-L1 as a Novel Biomarker to Predict Neuronal Apoptosis Following Deep Hypothermic Circulatory Arrest.Glial neuronal ratio: a novel index for differentiating injury type in patients with severe traumatic brain injury.Translating basic science research to clinical application: models and strategies for intracerebral hemorrhage.The diagnosis of traumatic brain injury on the battlefield.Biomarkers of focal and diffuse traumatic brain injury.Microwave-accelerated bioassay technique for rapid and quantitative detection of biological and environmental samples.Brain injury biomarkers may improve the predictive power of the IMPACT outcome calculator.Determination of Serum Lost Goodwill Target Proteome in Patients with Severe Traumatic Brain InjuryGlial fibrillary acidic protein as a biomarker in severe traumatic brain injury patients: a prospective cohort study.Autoimmune Profiling Reveals Peroxiredoxin 6 as a Candidate Traumatic Brain Injury BiomarkerGlial Fibrillary Acidic Protein Is Not an Early Marker of Injury in Perinatal Asphyxia and Hypoxic-Ischemic Encephalopathy.Exploratory study of serum ubiquitin carboxyl-terminal esterase L1 and glial fibrillary acidic protein for outcome prognostication after pediatric cardiac arrest.Therapy development for diffuse axonal injury.Assessment of Serum UCH-L1 and GFAP in Acute Stroke Patients.Year in review 2011: Critical Care--Neurocritical care.A military-centered approach to neuroprotection for traumatic brain injury.Traumatic brain injury: Changing concepts and approaches.Serum Concentrations of Ubiquitin C-Terminal Hydrolase-L1 and Glial Fibrillary Acidic Protein after Pediatric Traumatic Brain InjuryGFAP-BDP as an acute diagnostic marker in traumatic brain injury: results from the prospective transforming research and clinical knowledge in traumatic brain injury study.Elevated levels of serum glial fibrillary acidic protein breakdown products in mild and moderate traumatic brain injury are associated with intracranial lesions and neurosurgical intervention.Human Serum Metabolites Associate With Severity and Patient Outcomes in Traumatic Brain InjuryAcute biomarkers of traumatic brain injury: relationship between plasma levels of ubiquitin C-terminal hydrolase-L1 and glial fibrillary acidic protein.Serum glial fibrillary acidic protein as a specific marker for necrotizing meningoencephalitis in Pug dogs.
P2860
Q26741134-B13E9EAB-637A-403E-837D-E88270901F12Q26824124-EDC0EB53-855B-424C-8890-949ECB581848Q27016627-85E13A43-3666-475C-B13D-9FCF8AE7F98CQ28067275-A5F90277-106F-4BA1-B26E-E32195A31417Q28535264-1B5150E5-D5DE-4195-B045-FA96D96133FCQ28741573-2147914F-8165-48C9-9CD5-4F1ED0DE5F06Q30586077-37E26472-DF9D-47F4-8452-FF47AE47F8A3Q33863821-9E47CAF3-01F5-404B-8363-9B76E16C6A86Q34318048-20F1EA13-ADFD-49EC-8860-C4F522488645Q34397124-CB6AF07B-9137-418F-80C9-52CC493E0D8DQ34471118-2BB7512F-C814-4A80-80D7-B13A9A35649FQ34920400-E0100766-F708-42C5-9CE2-B5510C2CC434Q35131093-4BFF4E34-ADB6-43EB-9CDE-95DE08361949Q35136554-0CD54F92-B3BC-4D0C-8EF5-7CD888997341Q35164692-A78B958E-ACC0-496F-8322-B1C7853B0892Q35376450-7F9C0475-8122-45E4-9D82-F43A6E756605Q35729723-80E3D5B0-DB2D-4403-A4E9-6E2A1D779840Q35850990-2F5723E4-8FCC-4BBB-A55F-6896F4FA2043Q35886747-304F3E6D-C9A0-42CC-8927-A64B5F40BF67Q35993214-A9DE3DFF-0F0A-4472-9951-59A5C6CA2F69Q36026050-21C7FB8A-1BDA-4076-A35F-DE1199FFDFB7Q36070351-BBCDC72C-356F-40B6-A4DB-FAA91D958DDAQ36093532-31864D1C-9BDE-4852-9150-4B89712B57D0Q36131599-3F1AEDF1-2CB6-4D1A-92D4-A1AD280B5A4AQ36144992-9762BB52-4995-4742-817A-16517ADA51AEQ36146948-2A22F845-FC7C-4DEC-A82A-573BB9B65C80Q36294820-0B0008FA-DEF4-4D97-9C2F-02A848483995Q36387457-155C1133-699C-4CFE-A7F6-C34C8B835C2EQ36689419-08D69D2B-1A9A-43C0-A8C3-8B4BEF568151Q36768885-4970C39C-5A8D-4CBC-B97A-210484157F3AQ36796090-4256154B-AD7B-4BB7-B59E-F851F47F964FQ36902672-4D165FBE-7D09-4005-A6A8-CA0E325093F5Q36920836-849D97F5-5159-4778-AB89-8E6FB904EF57Q36980737-1DC069A0-B2AF-440A-A7AD-3B877EFB6F06Q37019440-764489D7-4A99-4D2D-88FB-7A222011F52DQ37115239-9D8D9765-946E-4C0C-8C00-55863E99025DQ37316677-80FAE9EC-EB81-419B-BA2A-5941FAD057F6Q37363452-31ED7649-0E16-4A30-AC37-EB4F88C58AA7Q37430560-04708CD1-FB61-4529-9570-689D405BC362Q37618328-AF5540C3-5235-4448-A78B-24CD28120575
P2860
Neuronal and glial markers are differently associated with computed tomography findings and outcome in patients with severe traumatic brain injury: a case control study.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Neuronal and glial markers are ...... injury: a case control study.
@ast
Neuronal and glial markers are ...... injury: a case control study.
@en
type
label
Neuronal and glial markers are ...... injury: a case control study.
@ast
Neuronal and glial markers are ...... injury: a case control study.
@en
prefLabel
Neuronal and glial markers are ...... injury: a case control study.
@ast
Neuronal and glial markers are ...... injury: a case control study.
@en
P2093
P2860
P356
P1433
P1476
Neuronal and glial markers are ...... injury: a case control study.
@en
P2093
Andras Buki
Endre Czeiter
Frank C Tortella
Linda Papa
M Ross Bullock
Ronald L Hayes
P2860
P2888
P356
10.1186/CC10286
P577
2011-06-24T00:00:00Z
P5875
P6179
1011752962